Advances in osteoclast biology: old findings and new insights from mouse models (original) (raw)

• Krane, S. M. & Inada, M. Matrix metalloproteinases and bone. Bone 43, 7–18 (2008).
  Article CAS PubMed Google Scholar
• Hertwig, P. Sechs neue mutationen bei der hausmaus in ihrer bedeutung für allgemeine vererbungsfragen. Z. Menschl. Vererb. Konstitutionsl. 26, 1–21 (1942).
  Google Scholar
• Grüneberg, H. A new sub-lethal colour mutation in the house mouse. Proc. R. Soc. Lond. B 118, 321–342 (1935).
  Article Google Scholar
• Dickie, M. Private communication. Mouse News Letter 36, 39 (1967).
  Google Scholar
• Walker, D. G. Spleen cells transmit osteopetrosis in mice. Science 190, 785–787 (1975).
  Article CAS PubMed Google Scholar
• Walker, D. G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 190, 784–785 (1975).
  Article CAS PubMed Google Scholar
• Walker, D. G. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J. Exp. Med. 142, 651–663 (1975).
  Article CAS PubMed Google Scholar
• Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444 (1990).
  Article CAS PubMed Google Scholar
• Marks, S. C. Jr & Lane, P. W. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67, 11–18 (1976).
  Article PubMed Google Scholar
• Wiktor-Jedrzejczak, W. W., Ahmed, A., Szczylik, C. & Skelly, R. R. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516–1527 (1982).
  Article CAS PubMed Google Scholar
• Arai, F. et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190, 1741–1754 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, D. E., Hetherington, C. J., Chen, H. M. & Tenen, D. G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell Biol. 14, 373–381 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Pahl, H. L. et al. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 268, 5014–5020 (1993).
  CAS PubMed Google Scholar
• Tondravi, M. M. et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81–84 (1997).
  Article CAS PubMed Google Scholar
• Hodgkinson, C. A. et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395–404 (1993).
  Article CAS PubMed Google Scholar
• Luchin, A. et al. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J. Bone Miner. Res. 15, 451–460 (2000).
  Article CAS PubMed Google Scholar
• Luchin, A. et al. Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J. Biol. Chem. 276, 36703–36710 (2001).
  Article CAS PubMed Google Scholar
• Rehli, M., Lichanska, A., Cassady, A. I., Ostrowski, M. C. & Hume, D. A. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J. Immunol. 162, 1559–1565 (1999).
  CAS PubMed Google Scholar
• Grigoriadis, A. E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443–448 (1994).
  Article CAS PubMed Google Scholar
• Matsumoto, M., Sudo, T., Marumaya, M., Osada, H. & Tsujimoto, M. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett. 486, 23–28 (2000).
  Article CAS PubMed Google Scholar
• Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309–319 (1997).
  Article CAS PubMed Google Scholar
• Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 95, 3597–3602 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176 (1998).
  Article CAS PubMed Google Scholar
• Wong, B. R. et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190–25194 (1997).
  Article CAS PubMed Google Scholar
• Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175–179 (1997).
  Article CAS PubMed Google Scholar
• Hsu, H. et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl Acad. Sci. USA 96, 3540–3545 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bucay, N. et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260–1268 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl Acad. Sci. USA 97, 1566–1571 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315–323 (1999).
  Article CAS PubMed Google Scholar
• Rothe, M., Sarma, V., Dixit, V. M. & Goeddel, D. V. TRAF2-mediated activation of NF-κ B by TNF receptor 2 and CD40. Science 269, 1424–1427 (1995).
  Article CAS PubMed Google Scholar
• Song, H. Y., Régnier, C. H., Kirschning, C. J., Goeddel, D. V. & Rothe, M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl Acad. Sci. USA 94, 9792–9796 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Nakano, H. et al. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271, 14661–14664 (1996).
  Article CAS PubMed Google Scholar
• Ishida, T. et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745–28748 (1996).
  Article CAS PubMed Google Scholar
• Yeh, W. C. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715–725 (1997).
  Article CAS PubMed Google Scholar
• Naito, A. et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4, 353–362 (1999).
  Article CAS PubMed Google Scholar
• Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015–1024 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Armstrong, A. P. et al. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J. Biol. Chem. 277, 44347–44356 (2002).
  Article CAS PubMed Google Scholar
• Bai, S. et al. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J. Clin. Invest. 115, 2742–2751 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gerondakis, S. et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781–6799 (2006).
  Article CAS PubMed Google Scholar
• Iotsova, V. et al. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3, 1285–1289 (1997).
  Article CAS PubMed Google Scholar
• Franzoso, G. et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482–3496 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Xing, L. et al. NF-κB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J. Bone Miner. Res. 17, 1200–1210 (2002).
  Article CAS PubMed Google Scholar
• Li, Q. et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1322–1328 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, K. et al. Limb and skin abnormalities in mice lacking IKKα. Science 284, 313–316 (1999).
  Article CAS PubMed Google Scholar
• Sil, A. K., Maeda, S., Sano, Y., Roop, D. R. & Karin, M. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428, 660–664 (2004).
  Article CAS PubMed Google Scholar
• Ruocco, M. G. et al. I{κ}B kinase (IKK){β}, but not IKK{α}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201, 1677–1687 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Edwards, J. R. et al. IκBα-deficient mice display increased osteoclast formation and activity and bone loss in vivo [abstract 1147]. J. Bone Miner. Res. 22 (Suppl. 1), S42 (2007).
  Google Scholar
• Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889–901 (2002).
  Article CAS PubMed Google Scholar
• Ranger, A. M. et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186–190 (1998).
  Article CAS PubMed Google Scholar
• de la Pompa, J. L. et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392, 182–186 (1998).
  Article CAS PubMed Google Scholar
• Winslow, M. M. et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771–782 (2006).
  Article CAS PubMed Google Scholar
• Negishi-Koga, T. & Takayanagi, H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241–256 (2009).
  Article CAS PubMed Google Scholar
• Koga, T. et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758–763 (2004).
  Article CAS PubMed Google Scholar
• Shinohara, M. et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132, 794–806 (2008).
  Article CAS PubMed Google Scholar
• Li, Y. et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109, 3839–3848 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kong, Y. Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304–309 (1999).
  Article CAS PubMed Google Scholar
• Roggia, C. et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl Acad. Sci. USA 98, 13960–13965 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Aubin, J. E. Osteoclast adhesion and resorption: the role of podosomes. J. Bone Miner. Res. 7, 365–368 (1992).
  Article CAS PubMed Google Scholar
• McHugh, K. P. et al. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105, 433–440 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693–702 (1991).
  Article CAS PubMed Google Scholar
• Blair, H. C. How the osteoclast degrades bone. Bioessays 20, 837–846 (1998).
  Article CAS PubMed Google Scholar
• Supanchart, C. & Kornak, U. Ion channels and transporters in osteoclasts. Arch. Biochem. Biophys. 473, 161–165 (2008).
  Article CAS PubMed Google Scholar
• Li, Y. P., Chen, W., Liang, Y., Li, E. & Stashenko, P. _Atp6i_-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23, 447–451 (1999).
  Article CAS PubMed Google Scholar
• Scimeca, J. C. et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26, 207–213 (2000).
  Article CAS PubMed Google Scholar
• Kornak, U. et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9, 2059–2063 (2000).
  Article CAS PubMed Google Scholar
• Michigami, T. et al. Novel mutations in the a3 subunit of vacuolar H(+)-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone 30, 436–439 (2002).
  Article CAS PubMed Google Scholar
• Lee, S. H. et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12, 1403–1409 (2006).
  Article CAS PubMed Google Scholar
• Boyce, B. F., Yoneda, T., Lowe, C., Soriano, P. & Mundy, G. R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90, 1622–1627 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–649 (2003).
  Article CAS PubMed Google Scholar
• Sly, W. S. & Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 64, 375–401 (1995).
  Article CAS PubMed Google Scholar
• Margolis, D. S., Szivek, J. A., Lai, L. W. & Lien, Y. H. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice. Calcif. Tissue Int. 82, 66–76 (2008).
  Article CAS PubMed Google Scholar
• Schlesinger, P. H., Blair, H. C., Teitelbaum, S. L. & Edwards, J. C. Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption. J. Biol. Chem. 272, 18636–18643 (1997).
  Article CAS PubMed Google Scholar
• Kornak, U. et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205–215 (2001).
  Article CAS PubMed Google Scholar
• Gelb, B. D., Shi, G. P., Chapman, H. A. & Desnick, R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236–1238 (1996).
  Article CAS PubMed Google Scholar
• Saftig, P. et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl Acad. Sci. USA 95, 13453–13458 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Gowen, M. et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14, 1654–1663 (1999).
  Article CAS PubMed Google Scholar
• Li, C. Y. et al. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J. Bone Miner. Res. 21, 865–875 (2006).
  Article CAS PubMed Google Scholar
• Delaissé, J. M. et al. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc. Res. Tech. 61, 504–513 (2003).
  Article PubMed CAS Google Scholar
• Vu, T. H. et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411–422 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Inada, M. et al. Critical roles for collagenase-3 (MMP13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl Acad. Sci. USA 101, 17192–17197 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Stickens, D. et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131, 5883–5895 (2004).
  Article CAS PubMed Google Scholar
• Kosaki, N. et al. Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem. Biophys. Res. Commun. 354, 846–851 (2007).
  Article CAS PubMed Google Scholar
• Hollberg, K., Hultenby, K., Hayman, A., Cox, T. & Andersson, G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp. Cell Res. 279, 227–238 (2002).
  Article CAS PubMed Google Scholar
• Watts, N. B. & Diab, D. L. Long-term use of bisphosphonates in osteoporosis. J. Clin. Endocrinol. Metab. 95, 1555–1565 (2010).
  Article CAS PubMed Google Scholar
• Bekker, P. J. et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J. Bone Miner. Res. 19, 1059–1066 (2004).
  Article CAS PubMed Google Scholar
• McClung, M. R. et al. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354, 821–831 (2006).
  Article CAS PubMed Google Scholar
• Bone, H. G. et al. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J. Bone Miner. Res. 25, 937–947 (2010).
  PubMed Google Scholar
• Stoch, S. A. et al. Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin. Pharmacol. Ther. 86, 175–182 (2009).
  Article CAS PubMed Google Scholar
• Ohno, H. et al. A c-Fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol. Cancer Ther. 5, 2634–2643 (2006).
  Article CAS PubMed Google Scholar
• Lark, M. W. et al. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Miner. Res. 16, 319–327 (2001).
  Article CAS PubMed Google Scholar
• Murphy, M. G. et al. Effect of L-000845704, an αVβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J. Clin. Endocrinol. Metab. 90, 2022–2028 (2005).
  Article CAS PubMed Google Scholar
• Lu, X. et al. A new osteopetrosis mutant mouse strain (ntl) with odontoma-like proliferations and lack of tooth roots. Eur. J. Oral Sci. 117, 625–635 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tang, Y. et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757–765 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kara, F. M. et al. Adenosine A1 receptors regulate bone resorption in mice: adenosine A1 receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A1 receptor-knockout mice. Arthritis Rheum. 62, 534–541 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Whyte, L. S. et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc. Natl Acad. Sci. USA 106, 16511–16516 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Iwasawa, M. et al. The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. J. Clin. Invest. 119, 3149–3159 (2009).
  CAS PubMed PubMed Central Google Scholar
• Martin-Millan, M. et al. The estrogen receptor-α in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323–334 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Imai, Y. et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann. NY Acad. Sci. 1173 (Suppl. 1), E31–E39 (2009).
  Article CAS PubMed Google Scholar
• Chan, A. S. et al. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS ONE 4, e7955 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Edwards, J. R. et al. The aging associated gene SIRT-1 regulates osteoclast formation and bone mass in vivo [abstract 1097]. J. Bone Miner. Res. 22 (Suppl. 1), S29 (2007).
  Google Scholar
• Mizoguchi, F. et al. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J. Cell Biochem. 109, 866–875 (2010).
  CAS PubMed Google Scholar